The lipid rafts in cancer stem cell: a target to eradicate cancer

Stem Cell Res Ther. 2022 Aug 30;13(1):432. doi: 10.1186/s13287-022-03111-8.

Abstract

Cancer stem cells (CSCs) are a subpopulation of cancer cells with stem cell properties that sustain cancers, which may be responsible for cancer metastasis or recurrence. Lipid rafts are cholesterol- and sphingolipid-enriched microdomains in the plasma membrane that mediate various intracellular signaling. The occurrence and progression of cancer are closely related to lipid rafts. Emerging evidence indicates that lipid raft levels are significantly enriched in CSCs compared to cancer cells and that most CSC markers such as CD24, CD44, and CD133 are located in lipid rafts. Furthermore, lipid rafts play an essential role in CSCs, specifically in CSC self-renewal, epithelial-mesenchymal transition, drug resistance, and CSC niche. Therefore, lipid rafts are critical regulatory platforms for CSCs and promising therapeutic targets for cancer therapy.

Keywords: Cancer; Cancer stem cell; Cancer stem cell niche; Drug resistance; Epithelial-mesenchymal transition; Lipid raft; Self-renewal.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Epithelial-Mesenchymal Transition
  • Humans
  • Membrane Microdomains / metabolism
  • Neoplasms* / metabolism
  • Neoplasms* / therapy
  • Neoplastic Stem Cells* / metabolism
  • Signal Transduction